Dr. Brad Thompson
Brad Thompson, Ph.D. is Chairman, CEO, & CTO at Wyvern Pharmaceuticals.
Brad is an experienced biotechnology company founder and company
executive, currently CEO at Kickshaw Ventures and Wyvern
Pharmaceuticals, and formerly CEO of Oncolytics Biotech, from
1999 to 2016 and CEO of Synsorb Biotech from 1994 to 1999.
He has served
as Chairman, Director and Audit Committee member on a number of other
public company (NASDAQ, TSX, CDNX) boards of directors, and private
company boards and industry groups (including Chairman and Chairman
Emeritus of BIOTECanada).
Brad earned his BSc in Microbiology in the University of Alberta in 1978
and his Ph.D. from the University of
Western Ontario in the Department of Microbiology and Immunology
in 1981.
Read his LinkedIn
profile.
